New Launch15 Jul 2025, 06:01 pm
Godavari Biorefineries Ltd Granted Patent by CNIPA for '5 Hydroxy-1, 4-Naphthalenedione' in Cancer Treatment
AI Summary
Godavari Biorefineries Ltd has announced that the China National Intellectual Property Administration (CNIPA) has granted a patent for '5-HYDROXY-1,4-NAPHTHALENEDIONE FOR USE IN THE TREATMENT OF CANCER'. This patent covers a new class of compounds that have shown strong inhibitory effects on cancer and cancer stem cells in vitro studies. The compounds have demonstrated significant efficacy against multiple cancer cell types, including breast and prostate cancer.
Key Highlights
- Godavari Biorefineries Ltd has been granted a patent by the CNIPA for '5-HYDROXY-1,4-NAPHTHALENEDIONE FOR USE IN THE TREATMENT OF CANCER'
- The patent covers a new class of compounds with strong inhibitory effects on cancer and cancer stem cells
- The compounds have demonstrated significant efficacy against multiple cancer cell types, including breast and prostate cancer